Rock Springs Capital Management as of March 31, 2016
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 127 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aetna | 3.9 | $46M | 411k | 112.35 | |
Allergan | 3.8 | $46M | 171k | 268.03 | |
Acadia Healthcare (ACHC) | 3.5 | $41M | 750k | 55.11 | |
Hca Holdings (HCA) | 2.8 | $34M | 430k | 78.05 | |
Baxalta Incorporated | 2.7 | $33M | 810k | 40.40 | |
Alexion Pharmaceuticals | 2.7 | $32M | 228k | 139.22 | |
Pfizer (PFE) | 2.6 | $31M | 1.0M | 29.64 | |
Gilead Sciences (GILD) | 2.5 | $30M | 330k | 91.86 | |
Advanced Accelerat spon ads each rep 2 ord | 2.4 | $29M | 833k | 35.02 | |
Radius Health | 2.1 | $25M | 809k | 31.44 | |
Intuitive Surgical (ISRG) | 2.1 | $25M | 42k | 601.05 | |
Celgene Corporation | 2.0 | $24M | 240k | 100.09 | |
WellCare Health Plans | 1.8 | $21M | 230k | 92.75 | |
Teva Pharmaceutical Industries (TEVA) | 1.8 | $21M | 395k | 53.51 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.7 | $21M | 1.1M | 18.15 | |
Medicines Company | 1.7 | $20M | 632k | 31.77 | |
Eli Lilly & Co. (LLY) | 1.7 | $20M | 276k | 72.01 | |
Pacira Pharmaceuticals (PCRX) | 1.4 | $17M | 327k | 52.98 | |
Spark Therapeutics | 1.4 | $17M | 581k | 29.51 | |
Aclaris Therapeutics (ACRS) | 1.4 | $17M | 896k | 18.95 | |
Anthem (ELV) | 1.4 | $17M | 121k | 138.99 | |
CIGNA Corporation | 1.4 | $17M | 122k | 137.24 | |
Tesaro | 1.4 | $17M | 380k | 44.03 | |
Neurocrine Biosciences (NBIX) | 1.3 | $16M | 405k | 39.55 | |
Thermo Fisher Scientific (TMO) | 1.2 | $14M | 100k | 141.59 | |
Amgen (AMGN) | 1.2 | $14M | 94k | 149.93 | |
Biogen Idec (BIIB) | 1.2 | $14M | 53k | 260.32 | |
Mednax (MD) | 1.1 | $13M | 195k | 64.62 | |
Prothena (PRTA) | 1.1 | $13M | 308k | 41.16 | |
McKesson Corporation (MCK) | 1.0 | $12M | 78k | 157.25 | |
Theravance Biopharma (TBPH) | 1.0 | $12M | 651k | 18.80 | |
Jazz Pharmaceuticals (JAZZ) | 0.9 | $11M | 86k | 130.55 | |
Bristol Myers Squibb (BMY) | 0.9 | $11M | 170k | 63.88 | |
Pra Health Sciences | 0.9 | $11M | 253k | 42.76 | |
Gw Pharmaceuticals Plc ads | 0.9 | $11M | 147k | 72.15 | |
Penumbra (PEN) | 0.9 | $11M | 229k | 46.00 | |
Walgreen Boots Alliance (WBA) | 0.9 | $10M | 124k | 84.24 | |
Therapeuticsmd | 0.8 | $10M | 1.6M | 6.40 | |
Incyte Corporation (INCY) | 0.8 | $9.5M | 131k | 72.47 | |
Achillion Pharmaceuticals | 0.8 | $9.4M | 1.2M | 7.72 | |
Anacor Pharmaceuticals In | 0.8 | $9.5M | 178k | 53.45 | |
Galapagos Nv- (GLPG) | 0.7 | $8.8M | 210k | 41.82 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $8.5M | 103k | 82.48 | |
Ardelyx (ARDX) | 0.7 | $8.2M | 1.1M | 7.77 | |
Wright Medical Group Nv | 0.7 | $8.1M | 490k | 16.60 | |
Healthsouth | 0.7 | $7.8M | 208k | 37.63 | |
Inovalon Holdings Inc Cl A | 0.7 | $7.9M | 427k | 18.52 | |
Invitae (NVTAQ) | 0.6 | $7.7M | 753k | 10.23 | |
Ultragenyx Pharmaceutical (RARE) | 0.6 | $7.5M | 119k | 63.31 | |
Juno Therapeutics | 0.6 | $7.5M | 197k | 38.09 | |
RTI Biologics | 0.6 | $7.4M | 1.9M | 4.00 | |
Cooper Companies | 0.6 | $7.3M | 48k | 153.97 | |
Epizyme | 0.6 | $7.1M | 589k | 12.12 | |
Retrophin | 0.6 | $7.1M | 521k | 13.66 | |
Seres Therapeutics (MCRB) | 0.6 | $7.0M | 262k | 26.56 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.6 | $6.7M | 84k | 79.49 | |
Edwards Lifesciences (EW) | 0.6 | $6.7M | 76k | 88.21 | |
Alkermes (ALKS) | 0.6 | $6.6M | 195k | 34.19 | |
Corvus Pharmaceuticals (CRVS) | 0.6 | $6.6M | 457k | 14.50 | |
Beigene (BGNE) | 0.6 | $6.6M | 225k | 29.31 | |
Intersect Ent | 0.5 | $6.5M | 340k | 19.00 | |
athenahealth | 0.5 | $6.3M | 46k | 138.78 | |
Novadaq Technologies | 0.5 | $6.2M | 555k | 11.09 | |
Adaptimmune Therapeutics (ADAP) | 0.5 | $6.2M | 765k | 8.13 | |
HeartWare International | 0.5 | $6.1M | 193k | 31.42 | |
Regeneron Pharmaceuticals (REGN) | 0.5 | $5.9M | 17k | 360.42 | |
Coherus Biosciences (CHRS) | 0.5 | $6.0M | 282k | 21.23 | |
Dermira | 0.5 | $6.0M | 290k | 20.68 | |
Insys Therapeutics | 0.5 | $5.8M | 366k | 15.99 | |
Five Prime Therapeutics | 0.5 | $5.9M | 145k | 40.63 | |
Insmed (INSM) | 0.5 | $5.7M | 450k | 12.67 | |
CHINA CORD Blood Corp | 0.5 | $5.3M | 880k | 6.07 | |
Envision Healthcare Hlds | 0.5 | $5.4M | 266k | 20.40 | |
Aduro Biotech | 0.5 | $5.3M | 415k | 12.81 | |
Intra Cellular Therapies (ITCI) | 0.4 | $5.2M | 188k | 27.80 | |
Amicus Therapeutics (FOLD) | 0.4 | $5.2M | 614k | 8.45 | |
XenoPort | 0.4 | $5.0M | 1.1M | 4.51 | |
Ascendis Pharma A S (ASND) | 0.4 | $5.0M | 270k | 18.55 | |
Cardiome Pharma | 0.4 | $4.9M | 1.2M | 4.09 | |
Tandem Diabetes Care | 0.4 | $4.9M | 563k | 8.71 | |
Compugen (CGEN) | 0.4 | $4.6M | 820k | 5.58 | |
Allergan Plc pfd conv ser a | 0.4 | $4.6M | 5.0k | 917.00 | |
Chiasma | 0.4 | $4.5M | 493k | 9.16 | |
Proteostasis Therapeutics In | 0.4 | $4.5M | 470k | 9.64 | |
Novavax | 0.4 | $4.4M | 853k | 5.16 | |
Portola Pharmaceuticals | 0.4 | $4.3M | 210k | 20.40 | |
Fibrogen (FGEN) | 0.4 | $4.3M | 204k | 21.29 | |
Macrogenics (MGNX) | 0.3 | $4.2M | 225k | 18.75 | |
Aimmune Therapeutics | 0.3 | $4.0M | 293k | 13.56 | |
Avexis | 0.3 | $3.9M | 143k | 27.24 | |
Perrigo Company (PRGO) | 0.3 | $3.8M | 30k | 127.93 | |
Genocea Biosciences | 0.3 | $3.7M | 480k | 7.74 | |
Kite Pharma | 0.3 | $3.7M | 80k | 45.91 | |
Otonomy | 0.3 | $3.6M | 240k | 14.92 | |
Nabriva Therapeutics | 0.3 | $3.4M | 380k | 8.96 | |
Medicines Company conv | 0.3 | $3.4M | 3.0M | 1.14 | |
Paratek Pharmaceuticals | 0.3 | $3.4M | 223k | 15.17 | |
Dynavax Technologies (DVAX) | 0.3 | $3.2M | 165k | 19.24 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $3.2M | 250k | 12.70 | |
Rigel Pharmaceuticals | 0.3 | $3.0M | 1.5M | 2.08 | |
Endochoice Hldgs | 0.3 | $3.1M | 590k | 5.21 | |
Novocure Ltd ord (NVCR) | 0.3 | $3.1M | 214k | 14.48 | |
Auris Med Hldg | 0.2 | $2.9M | 788k | 3.64 | |
Sarepta Therapeutics (SRPT) | 0.2 | $2.6M | 131k | 19.52 | |
Scynexis | 0.2 | $2.6M | 635k | 4.03 | |
Clovis Oncology | 0.2 | $2.4M | 125k | 19.20 | |
Alder Biopharmaceuticals | 0.2 | $2.4M | 98k | 24.49 | |
Dbv Technologies S A | 0.2 | $2.4M | 73k | 32.55 | |
Valeant Pharmaceuticals Int | 0.2 | $2.2M | 86k | 26.30 | |
Ophthotech | 0.2 | $2.2M | 52k | 42.27 | |
Dimension Therapeutics | 0.2 | $2.1M | 271k | 7.83 | |
Egalet | 0.2 | $2.1M | 300k | 6.86 | |
Nivalis Therapeutics | 0.2 | $2.0M | 489k | 4.17 | |
Tetraphase Pharmaceuticals | 0.2 | $1.9M | 400k | 4.63 | |
Assembly Biosciences | 0.2 | $2.0M | 390k | 5.02 | |
Anthera Pharmaceutcls | 0.1 | $1.6M | 450k | 3.62 | |
Cerulean Pharma | 0.1 | $1.7M | 625k | 2.71 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.7M | 434k | 3.94 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $1.4M | 270k | 5.27 | |
Intercept Pharmaceuticals In | 0.1 | $1.3M | 10k | 128.50 | |
Global Blood Therapeutics In | 0.1 | $1.2M | 78k | 15.86 | |
Orexigen Therapeutics | 0.1 | $926k | 1.7M | 0.56 | |
Puma Biotechnology (PBYI) | 0.1 | $925k | 32k | 29.37 | |
Sophiris Bio | 0.1 | $905k | 629k | 1.44 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $900k | 1.0M | 0.90 | |
Bluebird Bio (BLUE) | 0.1 | $850k | 20k | 42.50 | |
Mirna Therapeutics | 0.1 | $656k | 150k | 4.37 |